Jason Bednar
Stock Analyst at Piper Sandler
(2.33)
# 2,404
Out of 4,827 analysts
167
Total ratings
39.85%
Success rate
-2.29%
Average return
Main Sectors:
Stocks Rated by Jason Bednar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRMD KORU Medical Systems | Maintains: Neutral | $4.5 → $3.5 | $3.25 | +7.69% | 7 | May 8, 2025 | |
| MASI Masimo | Reiterates: Overweight | $215 → $200 | $157.74 | +26.79% | 15 | May 7, 2025 | |
| BDX Becton, Dickinson and Company | Downgrades: Neutral | $260 → $185 | $170.07 | +8.78% | 9 | May 2, 2025 | |
| LUNG Pulmonx | Reiterates: Overweight | $10 → $9 | $3.79 | +137.78% | 11 | May 1, 2025 | |
| ALGN Align Technology | Reiterates: Overweight | $235 → $250 | $183.41 | +36.31% | 30 | May 1, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $20 → $16 | $15.79 | +1.33% | 8 | Apr 30, 2025 | |
| HSIC Henry Schein | Maintains: Overweight | $83 → $77 | $69.03 | +11.55% | 7 | Apr 30, 2025 | |
| NVST Envista Holdings | Maintains: Neutral | $18 → $17 | $17.94 | -5.24% | 12 | Apr 30, 2025 | |
| SOLV Solventum | Maintains: Neutral | $84 → $80 | $67.45 | +18.62% | 4 | Apr 30, 2025 | |
| SHC Sotera Health Company | Maintains: Neutral | $15 → $13 | $13.27 | -2.03% | 2 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $42 → $34 | $17.52 | +94.06% | 10 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $116 → $112 | $96.40 | +16.18% | 10 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $5 → $4.5 | $2.24 | +100.89% | 3 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $120 → $115 | $83.73 | +37.35% | 12 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $260 → $265 | $227.62 | +16.42% | 9 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $8 → $6 | $1.72 | +248.84% | 5 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $7 | $2.76 | +153.62% | 5 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $3.5 → $1 | $0.19 | +438.50% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $310 → $372 | $543.74 | -31.58% | 4 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $95 | $71.16 | +33.50% | 1 | Apr 19, 2023 |
KORU Medical Systems
May 8, 2025
Maintains: Neutral
Price Target: $4.5 → $3.5
Current: $3.25
Upside: +7.69%
Masimo
May 7, 2025
Reiterates: Overweight
Price Target: $215 → $200
Current: $157.74
Upside: +26.79%
Becton, Dickinson and Company
May 2, 2025
Downgrades: Neutral
Price Target: $260 → $185
Current: $170.07
Upside: +8.78%
Pulmonx
May 1, 2025
Reiterates: Overweight
Price Target: $10 → $9
Current: $3.79
Upside: +137.78%
Align Technology
May 1, 2025
Reiterates: Overweight
Price Target: $235 → $250
Current: $183.41
Upside: +36.31%
DENTSPLY SIRONA
Apr 30, 2025
Maintains: Neutral
Price Target: $20 → $16
Current: $15.79
Upside: +1.33%
Henry Schein
Apr 30, 2025
Maintains: Overweight
Price Target: $83 → $77
Current: $69.03
Upside: +11.55%
Envista Holdings
Apr 30, 2025
Maintains: Neutral
Price Target: $18 → $17
Current: $17.94
Upside: -5.24%
Solventum
Apr 30, 2025
Maintains: Neutral
Price Target: $84 → $80
Current: $67.45
Upside: +18.62%
Sotera Health Company
Apr 23, 2025
Maintains: Neutral
Price Target: $15 → $13
Current: $13.27
Upside: -2.03%
Apr 23, 2025
Maintains: Overweight
Price Target: $42 → $34
Current: $17.52
Upside: +94.06%
Apr 23, 2025
Maintains: Overweight
Price Target: $116 → $112
Current: $96.40
Upside: +16.18%
Mar 28, 2025
Maintains: Overweight
Price Target: $5 → $4.5
Current: $2.24
Upside: +100.89%
Mar 7, 2025
Reiterates: Overweight
Price Target: $120 → $115
Current: $83.73
Upside: +37.35%
Feb 3, 2025
Maintains: Overweight
Price Target: $260 → $265
Current: $227.62
Upside: +16.42%
Nov 7, 2024
Maintains: Overweight
Price Target: $8 → $6
Current: $1.72
Upside: +248.84%
Aug 15, 2024
Reiterates: Overweight
Price Target: $7
Current: $2.76
Upside: +153.62%
Aug 7, 2024
Maintains: Overweight
Price Target: $3.5 → $1
Current: $0.19
Upside: +438.50%
Jan 3, 2024
Maintains: Outperform
Price Target: $310 → $372
Current: $543.74
Upside: -31.58%
Apr 19, 2023
Initiates: Overweight
Price Target: $95
Current: $71.16
Upside: +33.50%